Hormonal
Resistance training improves insulin sensitivity and glucose uptake in individuals at risk for Type 2 Diabetes, acting synergistically with the reduction of low-grade systemic inflammation to prevent disease progression.
If you are at risk for Type 2 Diabetes, resistance training is a critical tool. It directly improves your muscles' ability to take up glucose and reduces the chronic inflammation that drives insulin resistance. Combine it with other healthy habits for the best protection against diabetes.
RT improves insulin sensitivity and glucose uptake by the muscle... RT can impact IR and T2DM in at least two synergistic manners: first by decreasing low grade systemic inflammation and second by improving glucose uptake by the muscle.
Why this rating
The paper states that the beneficial effects of RT on glucose metabolism are 'well established' and cites multiple references, though it notes scarce data specifically on RT's effect on inflammation in T2DM risk compared to endurance.
Source
Effects of resistance training on the inflammatory response
Mariana C. Calle et al. · Nutrition Research and Practice · 2010
DOI 10.4162/nrp.2010.4.4.259
More from this paper
- Long-term resistance training reduces basal levels of C-reactive protein (CRP) in overweight, obese, and older populations, thereby mitigating low-grade systemic inflammation associated with insulin resistance and cardiovascular risk.Moderate
- Acute resistance training increases plasma Interleukin-6 (IL-6) levels, which acts as an anti-inflammatory myokine when derived from muscle, promoting fat oxidation via AMPK activation and inhibiting pro-inflammatory cytokines like TNF-α.Moderate
Related findings · Hormonal
- Initial treatment for type 2 diabetes should be a combination of metformin and either an SGLT-2 inhibitor or a GLP-1 receptor agonist to achieve cardiorenal protection, rather than monotherapy or older agents like sulfonylureas.Strong
- For patients with specific monogenic obesity syndromes (leptin deficiency, POMC/PCSK1/LEPR mutations), targeted pharmacotherapy (recombinant leptin or setmelanotide) is highly effective and should be prioritized, unlike in polygenic obesity.Strong
- Continued weekly administration of 2.4 mg subcutaneous semaglutide prevents weight regain and promotes further weight loss in adults with overweight or obesity, whereas switching to placebo results in significant weight regain.Strong
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →